#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Extraskeletal ossification Hypoxic-ischaemic encephalopathy Myeloid leukaemia Amyloidosis Angiosarcoma non-metastatic Leiomyosarcoma Liver abscess Cystic fibrosis Hereditary hypophosphataemic rickets Blood iron increased Pancreatic carcinoma metastatic Albright's disease Superficial vein thrombosis Malignant peritoneal neoplasm Cholangiosarcoma More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Trials in Disease Synovial sarcoma metastatic – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease Mantle cell lymphoma refractory – Basic Information Malignant fibrous histiocytoma – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Basic Information Familial amyotrophic lateral sclerosis Hypereosinophilic syndrome – Basic Information Phenylketonuria – Basic Information Burkitt’s lymphoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Apraglutide Blu-451 Simoctocog Alfa Mifepristone OXYBUTYNIN HYDROCHLORIDE PEGZILARGINASE Levetiracetam Bleomycin Sulfate Ph. Eur. Dactinomycin SOVATELTIDE Diroximel Fumarate Bilastine Dapagliflozin Absk021 Hydrochloride Hydrate Risedronate Sodium Niraparib Gemcitabine Hydrochloride Folic Acid, Anhydrous GSKVX000000034798 Netupitant More therapies…

    Learn about Your Condition

    Cervix carcinoma Morning sickness Leukoencephalopathy Depression Hepatic cirrhosis Leukocyte adhesion deficiency Cholestatic pruritus Skin disorder Coeliac disease Malignant glioma Thalassaemia alpha Gastrointestinal carcinoma Oropharyngeal cancer recurrent Raynaud's phenomenon Ovarian cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of lung
    • Non-small cell lung cancer stage IV
    • Non-small cell lung cancer
    Investigated Drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    • Mps-103
    Belgium France Germany Greece Hungary Italy +5

  • Study on Bezafibrate for Patients with Primary Biliary Cholangitis Not Responding Well to Ursodeoxycholic Acid

    Recruiting

    3 1 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Bezafibrate
    France

  • Study of EGL-001 for Adults with Advanced or Metastatic Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Egl-001
    • Pembrolizumab
    France Spain

  • Study on Early Erectile Rehabilitation with Sildenafil for Men After Rectal Cancer Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Sildenafil
    France

  • Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ttf-Ngr
    Germany

  • Study on Early Treatment of Patent Ductus Arteriosus with Paracetamol in Extremely Low Birth Weight Infants

    Recruiting

    3 1 1
    Investigated Diseases:
    • Patent ductus arteriosus
    Investigated Drugs:
    • Paracetamol
    • Sodium Chloride
    Czechia Ireland
Previous Page
1 … 356 357 358 359 360 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!